logo

MBRX

Moleculin Biotech·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
4.27 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is MBRX a Good Buy Right Now?
  • Based on a composite score of 4.27/10, we rate MBRX as a Netural. Our analysis breaks down into 5.00/10 for Fundamentals, 2.80/10 for Technicals, and 4.63/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is MBRX undervalued or overvalued?
Technical Analysis of MBRX?
Is money flowing into or out of MBRX?